Works matching IS 1470269X AND DT 2009 AND VI 9 AND IP 1

Results: 9

Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 61, doi. 10.1038/sj.tpj.6500491

By:

Wilkie, M. J. V.;
Smith, G.;
Day, R. K.;
Matthews, K.;
Smith, D.;
Blackwood, D.;
Reid, I. C.;
Wolf, C. R.

Publication type:

Article

DRD4 48 bp VNTR but not 5-HT<sub>2C</sub> Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 71, doi. 10.1038/tpj.2008.5

By:

Popp, J.;
Leucht, S.;
Heres, S.;
Steimer, W.

Publication type:

Article

Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 14, doi. 10.1038/tpj.2008.11

By:

Bromley, C. M.;
Close, S.;
Cohen, N.;
Favis, R.;
Fijal, B.;
Gheyas, F.;
Liu, W.;
Lopez-Correa, C.;
Prokop, A.;
Singer, J. B.;
Snapir, A.;
Tchelet, A.;
Wang, D.;
Goldstaub, D.

Publication type:

Article

The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 34, doi. 10.1038/tpj.2008.7

By:

Rebsamen, M. C.;
Desmeules, J.;
Daali, Y.;
Chiappe, A.;
Diemand, A.;
Rey, C.;
Chabert, J.;
Dayer, P.;
Hochstrasser, D.;
Rossier, M. F.

Publication type:

Article

Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 49, doi. 10.1038/tpj.2008.13

By:

Perera, M. A.;
Thirumaran, R. K.;
Cox, N. J.;
Hanauer, S.;
Das, S.;
Brimer-Cline, C.;
Lamba, V.;
Schuetz, E. G.;
Ratain, M. J.;
Di Rienzo, A.

Publication type:

Article

Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 42, doi. 10.1038/tpj.2008.2

By:

Schwarz, P. E. H.;
Towers, G. W.;
van der Merwe, A.;
Perez-Perez, L.;
Rheeder, P.;
Schulze, J.;
Bornstein, S. R.;
Licinio, J.;
Wong, M.-L.;
Schutte, A. E.;
Olckers, A.

Publication type:

Article

Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 23, doi. 10.1038/tpj.2008.4

By:

Nelson, M. R.;
Bacanu, S.-A.;
Mosteller, M.;
Li, L.;
Bowman, C. E.;
Roses, A. D.;
Lai, E. H.;
Ehm, M. G.

Publication type:

Article

Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 78, doi. 10.1038/tpj.2008.16

By:

Graziano, F.;
Ruzzo, A.;
Canestrari, E.;
Loupakis, F.;
Santini, D.;
Rulli, E.;
Humar, B.;
Galluccio, N.;
Bisonni, R.;
Floriani, I.;
Maltese, P.;
Falcone, A.;
Tonini, G.;
Catalano, V.;
Fontana, A.;
Giustini, L.;
Masi, G.;
Vincenzi, B.;
Alessandroni, P.;
Magnani, M.

Publication type:

Article

The impact of microRNAs and alternative splicing in pharmacogenomics.

Published in:

Pharmacogenomics Journal, 2009, v. 9, n. 1, p. 1, doi. 10.1038/tpj.2008.14

By:

Passetti, F.;
Ferreira, C. G.;
Costa, F. F.

Publication type:

Article